Nationwide experience of catecholaminergic polymorphic ventricular tachycardia caused by RyR2 mutations

AK Broendberg, JC Nielsen, J Bjerre, LN Pedersen… - Heart, 2017 - heart.bmj.com
Objective The aim of this study was to characterise disease penetrance, course of disease
and use of antiarrhythmic medication and implantable cardioverter-defibrillator (ICD) therapy …
被引用次数：27 相关文章

Nationwide experience of catecholaminergic polymorphic ventricular tachycardia caused by RyR2 mutations

AK Broendberg, JC Nielsen, J Bjerre… - Heart, 2017 - portal.findresearcher.sdu.dk
OBJECTIVE: The aim of this study was to characterise disease penetrance, course of
disease and use of antiarrhythmic medication and implantable cardioverter-defibrillator …

Nationwide experience of catecholaminergic polymorphic ventricular tachycardia caused by RyR2 mutations

AK Broendberg, JC Nielsen, J Bjerre… - Heart (British …, 2017 - research.regionh.dk
OBJECTIVE: The aim of this study was to characterise disease penetrance, course of
disease and use of antiarrhythmic medication and implantable cardioverter-defibrillator …

Nationwide experience of catecholaminergic polymorphic ventricular tachycardia caused by RyR2 mutations

AK Broendberg, JC Nielsen, J Bjerre, LN Pedersen… - Heart, 2017 - heart.bmj.com
Objective The aim of this study was to characterise disease penetrance, course of disease
and use of antiarrhythmic medication and implantable cardioverter-defibrillator (ICD) therapy …

Nationwide experience of catecholaminergic polymorphic ventricular tachycardia caused by RyR2 mutations

AK Broendberg, JC Nielsen, J Bjerre… - Heart (British …, 2017 - pubmed.ncbi.nlm.nih.gov
Objective The aim of this study was to characterise disease penetrance, course of disease
and use of antiarrhythmic medication and implantable cardioverter-defibrillator (ICD) therapy …

Nationwide experience of catecholaminergic polymorphic ventricular tachycardia caused by RyR2 mutations.

AK Broendberg, JC Nielsen, J Bjerre… - Heart (British Cardiac …, 2017 - europepmc.org
Objective The aim of this study was to characterise disease penetrance, course of disease
and use of antiarrhythmic medication and implantable cardioverter-defibrillator (ICD) therapy …

Nationwide experience of catecholaminergic polymorphic ventricular tachycardia caused by RyR2 mutations

AK Broendberg, JC Nielsen, J Bjerre, LN Pedersen… - Heart, 2017 - search.proquest.com
Objective The aim of this study was to characterise disease penetrance, course of disease
and use of antiarrhythmic medication and implantable cardioverter-defibrillator (ICD) therapy …

Nationwide experience of catecholaminergic polymorphic ventricular tachycardia caused by RyR2 mutations

AK Broendberg, JC Nielsen, J Bjerre, LN Pedersen… - Heart, 2017 - pure.au.dk
OBJECTIVE: The aim of this study was to characterise disease penetrance, course of
disease and use of antiarrhythmic medication and implantable cardioverter-defibrillator …